Oscillating Positive Expiratory Pressure (OPEP) Devices Market Leading companies AirPhysio, Mercury Medical, Able Healthcare, D•R BURTON HEALTHCARE

Oscillatory positive expiratory pressure (OPEP) devices have been in use as a supplement to traditional chest physiotherapy (CPT) to aid the clearing of respiratory secretions in people who can't cough, especially those with chronic conditions. The use of OPEP devices is still limited in chronic airway disorders such as cystic fibrosis, bronchiectasis, bronchitis, bronchial asthma, and primary ciliary dyskinesia syndrome. In chronic obstructive pulmonary disease (COPD), oscillating positive expiratory pressure (OPEP) devices help with sputum clearance.

The oscillating positive expiratory pressure (OPEP) devices market is projected to grow from US$ 125.66 million in 2021 to US$ 179.34 million by 2028; it is estimated to grow at a CAGR of 5.2% during 2021-2028.

Download sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00015230/?utm_source=OpenPR&utm_medium=10144

Allergan Plc.; PARI GmbH; Smiths Medical; AirPhysio; D•R BURTON HEALTHCARE; Medica Holdings, LLC; CEGLA Medizintechnik GmbH & Co. KG; Able Healthcare; Trudell Medical International; and Mercury Medica are among the leading companies operating in the oscillating positive expiratory pressure (OPEP) devices market.

Based on product, the oscillating positive expiratory pressure (OPEP) devices market is segmented into face mask PEP devices, mouthpiece PEP devices, and bottle PEP devices. In 2021, the mouthpiece PEP devices held the largest share of the market. The market for this segment is expected to witness the highest CAGR during the forecast period. Mouthpiece PEP helps remove mucus from the lungs. It can also prevent lung collapse or open up areas that have collapsed. One of the key factors driving the market for this segment is the growing elderly population, accompanied by higher rates of chronic illnesses such as chronic obstructive pulmonary disease (COPD) and asthma.

COVID-19 has placed a tremendous strain on healthcare systems globally. According to World Health Organization (WHO), the demand for diagnostic and therapeutic devices increased dramatically in hospitals with the chaotic situation erupted in the healthcare sector. Many health authorities shifted their focus on pandemic-related care in 2020. They postponed elective surgeries, suspended outpatient clinics, and triaged employees involved in urgent care to lower the disease transmission rate at hospitals. However, treating chronic obstructive pulmonary disease (COPD) became critical as these patients are at a greater risk of more adverse outcomes. Positive expiratory pressure (PEP) devices are used as a self-care product by COPD and Covid 19 patients; this device can avoid pneumonia in leukemia patients, probably by reducing evident lung infiltrates via alveolar inflating and secretion relaxation. It can enhance airway clearance and boost functional residual capacity. PEP consumption has been linked to improved gas exchange and reduced atelectasis. Thus, these factors have shown steady growth to the oscillating positive expiratory pressure (OPEP) devices market.

Asthma affects more than 25 million people in the US, which equates to 7.7% of adults and 8.4% of children. According to the 2018 Global Asthma Report about Auckland, New Zealand, asthma ranks 16th among the largest causes of disability and 28th among the greatest sources of disease burden, as assessed by disability-adjusted life years. It is common in high-income countries, whereas the majority of asthma-related deaths occur in low- and middle-income countries. Therefore, the rising prevalence of COPD and asthma propels the demand for mucous clearing devices, such as OPEP devices, which bolsters the growth of the oscillating positive expiratory pressure (OPEP) devices market.

Place a Purchase Order to Buy a Complete Copy of this Report @ https://www.theinsightpartners.com/buy/TIPRE00015230/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

This release was published on openPR.